By: Charissa On: April 8, 2021 In:

Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug...

Read more
By: Charissa On: November 23, 2020 In:

Novosteo Inc. is developing novel therapeutics for the treatment of bone injury and diseases that impact patient mobility and...

Read more
By: Charissa On: November 20, 2020 In:

Siege Pharmaceuticals is developing new cancer drugs based on a naturally-occurring molecule that starves cancer cells to death.

Read more
By: Charissa On: November 20, 2020 In:

NVasc, Inc. is an early-stage ophthalmology company focused on the treatment of ischemic eye diseases, such as age-related macular...

Read more
By: Charissa On: September 22, 2020 In:

The world’s first COVID-19 testing device using RT-PCR, the gold standard of testing, to provide high accuracy results in...

Read more
By: Charissa On: January 11, 2020 In:

Pinpoint Therapeutics is developing novel cancer treatment options aimed to specifically inhibit autophagy, a key cell survival and treatment...

Read more
By: Charissa On: May 28, 2019 In:

Actuate Therapeutics is a clinical stage therapeutics company focusing on the treatment of high impact cancers and inflammatory diseases.

Read more
By: Charissa On: November 12, 2018 In:

Linnaeus Therapeutics is a clinical-stage biotech company engaged in the identification and development of small molecule agents that modulate...

Read more
By: Charissa On: June 25, 2018 In:

LifeSprout is a seed-stage biotechnology company dedicated to developing the next-generation of injectable soft tissue restoration products including nanofiber-hydrogel...

Read more
By: Charissa On: April 26, 2018 In:

Keren Therapeutics is taking a metabolic and endocrine approach to restoring muscle function and age-related cognitive decline.

Read more